• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用现有和新型临床相关性指标对革兰氏阴性尿分离株中的耐药性进行表征:一项为期10年的数据分析。

Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis.

作者信息

Gajdács Márió, Bátori Zoltán, Ábrók Marianna, Lázár Andrea, Burián Katalin

机构信息

Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Eötvös utca 6., Hungary.

Department of Ecology, Faculty of Sciences, University of Szeged, 6726 Szeged, Közép fasor 52., Hungary.

出版信息

Life (Basel). 2020 Feb 11;10(2):16. doi: 10.3390/life10020016.

DOI:10.3390/life10020016
PMID:32054054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7175163/
Abstract

Classical resistance classifications (multidrug resistance [MDR], extensive drug resistance [XDR], pan-drug resistance [PDR]) are very useful for epidemiological purposes, however, they may not correlate well with clinical outcomes, therefore, several novel classification criteria (e.g., usual drug resistance [UDR], difficult-to-treat resistance [DTR]) were introduced for Gram-negative bacteria in recent years. Microbiological and resistance data was collected for urinary tract infections (UTIs) retrospectively, corresponding to the 2008.01.01-2017.12.31. period. Isolates were classified into various resistance categories (wild type/susceptible, UDR, MDR, XDR, DTR and PDR), in addition, two new indicators (modified DTR; mDTR and mcDTR) and a predictive composite score (pMAR) were introduced. Results n = 16,240 (76.8%) outpatient and n = 13,386 (69.3%) inpatient UTI isolates were relevant to our analysis. had the highest level of UDR isolates (88.9%), the group had the highest mDTR levels. MDR levels were highest in spp. (9.7%) and (9.1%). XDR- and DTR-levels were higher in non-fermenters (XDR: 1.7%-4.7%. DTR: 7.3%-7.9%) than in isolates (XDR: 0%-0.1%. DTR: 0.02%-1.5%). Conclusions The introduction of DTR (and its' modifications detailed in this study) to the bedside and in clinical practice will definitely lead to substantial benefits in the assessment of the significance of bacterial resistance in human therapeutics.

摘要

经典的耐药性分类(多重耐药 [MDR]、广泛耐药 [XDR]、全耐药 [PDR])对于流行病学目的非常有用,然而,它们可能与临床结果相关性不佳,因此,近年来针对革兰氏阴性菌引入了几种新的分类标准(例如,常见耐药 [UDR]、难治性耐药 [DTR])。回顾性收集了2008年1月1日至2017年12月31日期间尿路感染(UTI)的微生物学和耐药性数据。分离株被分类为各种耐药类别(野生型/敏感、UDR、MDR、XDR、DTR和PDR),此外,还引入了两个新指标(改良DTR;mDTR和mcDTR)和一个预测性综合评分(pMAR)。结果n = 16,240(76.8%)门诊和n = 13,386(69.3%)住院UTI分离株与我们的分析相关。 组的UDR分离株水平最高(88.9%), 组的mDTR水平最高。MDR水平在 菌属(9.7%)和 菌属(9.1%)中最高。非发酵菌的XDR和DTR水平(XDR:1.7% - 4.7%,DTR:7.3% - 7.9%)高于 分离株(XDR:0% - 0.1%,DTR:0.02% - 1.5%)。结论将DTR(以及本研究中详细描述的其修改形式)引入床边和临床实践肯定会在评估人类治疗中细菌耐药性的重要性方面带来实质性益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/d42978789c55/life-10-00016-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/e4e78508a677/life-10-00016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/947c73a52d5d/life-10-00016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/5d3be259fc51/life-10-00016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/f8d2b5278996/life-10-00016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/cc1a1c24e13e/life-10-00016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/a06a170064cf/life-10-00016-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/c0aa6675de3d/life-10-00016-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/71dcc570ca23/life-10-00016-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/308d0f25ae1c/life-10-00016-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/05faf7a27d81/life-10-00016-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/549f1b8fbaaa/life-10-00016-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/d42978789c55/life-10-00016-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/e4e78508a677/life-10-00016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/947c73a52d5d/life-10-00016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/5d3be259fc51/life-10-00016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/f8d2b5278996/life-10-00016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/cc1a1c24e13e/life-10-00016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/a06a170064cf/life-10-00016-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/c0aa6675de3d/life-10-00016-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/71dcc570ca23/life-10-00016-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/308d0f25ae1c/life-10-00016-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/05faf7a27d81/life-10-00016-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/549f1b8fbaaa/life-10-00016-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a088/7175163/d42978789c55/life-10-00016-g012.jpg

相似文献

1
Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis.使用现有和新型临床相关性指标对革兰氏阴性尿分离株中的耐药性进行表征:一项为期10年的数据分析。
Life (Basel). 2020 Feb 11;10(2):16. doi: 10.3390/life10020016.
2
Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.革兰阴性血流感染患者中难治性耐药新定义的预后效用
Open Forum Infect Dis. 2019 Dec 12;6(12):ofz505. doi: 10.1093/ofid/ofz505. eCollection 2019 Dec.
3
Interplay between Phenotypic Resistance to Relevant Antibiotics in Gram-Negative Urinary Pathogens: A Data-Driven Analysis of 10 Years' Worth of Antibiogram Data.革兰氏阴性尿路病原体对相关抗生素的表型耐药性之间的相互作用:基于10年药敏数据的数据分析
Life (Basel). 2021 Oct 8;11(10):1059. doi: 10.3390/life11101059.
4
What Doesn't Kill Them Makes Them Stronger: The Impact of the Resistance Patterns of Urinary Isolates in Patients from a Tertiary Hospital in Eastern Europe.那些未能置人于死地的,会使人变得更强大:东欧一家三级医院患者尿液分离株耐药模式的影响
Antibiotics (Basel). 2022 Apr 20;11(5):548. doi: 10.3390/antibiotics11050548.
5
Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections.肾移植受者发生尿路感染时多重耐药/广泛耐药革兰阴性菌感染的流行病学、易感性及危险因素
Infect Drug Resist. 2018 May 14;11:707-715. doi: 10.2147/IDR.S163979. eCollection 2018.
6
Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.评价三甲氧氨磷霉素在土耳其社区获得性和医院获得性尿路感染分离的革兰阴性菌中的体外活性。
Int J Infect Dis. 2013 Nov;17(11):e966-70. doi: 10.1016/j.ijid.2013.04.005. Epub 2013 Jun 3.
7
Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana.加纳一所教学医院的耐多药革兰氏阴性菌感染。
Antimicrob Resist Infect Control. 2018 Mar 9;7:37. doi: 10.1186/s13756-018-0324-2. eCollection 2018.
8
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].头孢唑肟对各种临床分离株抗菌活性的上市后监测——II. 革兰氏阴性菌
Jpn J Antibiot. 2002 Feb;55(1):22-60.
9
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study.葡萄牙重症监护病房中引起泌尿道、腹腔内和下呼吸道感染的肠杆菌科和铜绿假单胞菌的头孢洛扎他唑巴坦的体外活性:STEP 多中心研究。
Int J Antimicrob Agents. 2020 Mar;55(3):105887. doi: 10.1016/j.ijantimicag.2020.105887. Epub 2020 Jan 8.
10
Prevalence and Antibiotic Resistance of ESKAPE Pathogens Isolated in the Emergency Department of a Tertiary Care Teaching Hospital in Hungary: A 5-Year Retrospective Survey.匈牙利一家三级护理教学医院急诊科分离出的ESKAPE病原体的流行情况及抗生素耐药性:一项5年回顾性调查
Antibiotics (Basel). 2020 Sep 19;9(9):624. doi: 10.3390/antibiotics9090624.

引用本文的文献

1
Using a difficult-to-treat resistance index to gauge imbalance between countries' antibiotic resistance prevalence and access to antibiotics: a scoping review and concept proposal.使用难以治疗的耐药指数衡量各国抗生素耐药性流行率与抗生素可及性之间的失衡:一项范围综述与概念提案
Clin Microbiol Infect. 2025 Jul;31(7):1126-1138. doi: 10.1016/j.cmi.2025.02.029. Epub 2025 Mar 1.
2
Epidemiological insights into seasonal, sex‑specific and age‑related distribution of bacterial pathogens in urinary tract infections.关于尿路感染中细菌病原体的季节性、性别特异性和年龄相关性分布的流行病学见解。
Exp Ther Med. 2024 Feb 14;27(4):140. doi: 10.3892/etm.2024.12428. eCollection 2024 Apr.
3

本文引用的文献

1
[Physicians' opinions towards antibiotic use and resistance in the southeastern region of Hungary].[匈牙利东南部地区医生对抗生素使用和耐药性的看法]
Orv Hetil. 2020 Mar;161(9):330-339. doi: 10.1556/650.2019.31598.
2
Knowledge, Attitude and Practice of Community Pharmacists Regarding Antibiotic Use and Infectious Diseases: A Cross-Sectional Survey in Hungary (KAPPhA-HU).匈牙利社区药剂师对抗生素使用和传染病的知识、态度与实践:一项横断面调查(KAPPhA-HU)
Antibiotics (Basel). 2020 Jan 21;9(2):41. doi: 10.3390/antibiotics9020041.
3
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship.
Analysis of Cumulative Antibiogram Reports in Search for Optimal Empirical Urinary Tract Infection Treatment at the Central Teaching Hospital of the Medical University of Lodz, Poland: Results of a 3-Year Surveillance.
波兰罗兹医科大学中央教学医院累积抗菌谱报告分析以寻求最佳经验性尿路感染治疗方案:三年监测结果
J Clin Med. 2023 Sep 28;12(19):6270. doi: 10.3390/jcm12196270.
4
Uropathogens' Antibiotic Resistance Evolution in a Female Population: A Sequential Multi-Year Comparative Analysis.女性人群中尿路病原体的抗生素耐药性演变:一项多年序贯比较分析
Antibiotics (Basel). 2023 May 23;12(6):948. doi: 10.3390/antibiotics12060948.
5
Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.加蓬东南部儿科人群中主要耐多药 ESKAPE 尿路病原体社区来源的流行病学。
Antimicrob Resist Infect Control. 2023 May 12;12(1):47. doi: 10.1186/s13756-023-01250-y.
6
In vitro synergistic interaction of colistin and other antimicrobials against intrinsic colistin-resistant isolates.黏菌素与其他抗菌药物对固有耐黏菌素分离株的体外协同相互作用。
3 Biotech. 2023 May;13(5):127. doi: 10.1007/s13205-023-03551-w. Epub 2023 Apr 12.
7
Phenotypical Detection of β-Lactamases in a Multidrug-Resistant and Extensively Drug-Resistant : A Rare Human Pathogen With Special References to Risk Factor.多重耐药和广泛耐药中的β-内酰胺酶表型检测:一种具有特殊危险因素参考的罕见人类病原体
Microbiol Insights. 2023 Jan 29;16:11786361221150755. doi: 10.1177/11786361221150755. eCollection 2023.
8
Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date.美罗培南-巴坦合剂治疗尿路感染的临床评估:迄今证据
Infect Drug Resist. 2023 Jan 26;16:555-568. doi: 10.2147/IDR.S187360. eCollection 2023.
9
What Doesn't Kill Them Makes Them Stronger: The Impact of the Resistance Patterns of Urinary Isolates in Patients from a Tertiary Hospital in Eastern Europe.那些未能置人于死地的,会使人变得更强大:东欧一家三级医院患者尿液分离株耐药模式的影响
Antibiotics (Basel). 2022 Apr 20;11(5):548. doi: 10.3390/antibiotics11050548.
10
Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm?新冠疫情是否改变了女性患者尿路病原体的抗生素耐药性?一场新的风暴?
Antibiotics (Basel). 2022 Mar 10;11(3):376. doi: 10.3390/antibiotics11030376.
碳青霉烯类药物节约策略:碳青霉烯酶、治疗和管理。
Curr Opin Infect Dis. 2019 Dec;32(6):663-673. doi: 10.1097/QCO.0000000000000598.
4
Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot.住院患者和门诊患者尿路感染中非发酵革兰氏阴性菌的耐药水平及流行病学(RENFUTI):十年流行病学概况
Antibiotics (Basel). 2019 Sep 9;8(3):143. doi: 10.3390/antibiotics8030143.
5
Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey.住院患者和门诊患者念珠菌尿症及念珠菌性尿路感染的流行病学:一项10年回顾性调查结果
Cent European J Urol. 2019;72(2):209-214. doi: 10.5173/ceju.2019.1909. Epub 2019 Jun 29.
6
Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy.肠杆菌科细菌中的碳青霉烯酶:检测与抗菌治疗
Front Microbiol. 2019 Aug 20;10:1823. doi: 10.3389/fmicb.2019.01823. eCollection 2019.
7
Antibiotic Resistance: From the Bench to Patients.抗生素耐药性:从实验室到患者
Antibiotics (Basel). 2019 Aug 27;8(3):129. doi: 10.3390/antibiotics8030129.
8
Comparative Epidemiology and Resistance Trends of in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study.住院患者和门诊患者尿路感染的比较流行病学及耐药趋势:一项10年回顾性研究。
Antibiotics (Basel). 2019 Jul 11;8(3):91. doi: 10.3390/antibiotics8030091.
9
Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study.比较三级医院常见尿路病原体的流行病学和耐药趋势:一项为期 10 年的监测研究。
Medicina (Kaunas). 2019 Jul 9;55(7):356. doi: 10.3390/medicina55070356.
10
The Role of Antibiotic Stewardship in Promoting Appropriate Antibiotic Use.抗生素管理在促进合理使用抗生素中的作用。
Am J Lifestyle Med. 2017 Apr 4;13(4):376-383. doi: 10.1177/1559827617700824. eCollection 2019 Jul-Aug.